Cargando...
A soluble activator that favors the ex vivo expansion of CD8(+)CD27(+) T cells
Adoptive cell therapy involves the infusion of tumor-reactive T cells into patients with cancer to provide antitumor immunity. The ex vivo expansion and differentiation of such T cells are key parameters that affect their therapeutic potential. Human T cells are presently expanded in culture through...
Guardado en:
| Publicado en: | JCI Insight |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Clinical Investigation
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7710272/ https://ncbi.nlm.nih.gov/pubmed/33208551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.141293 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|